US Patent Issued to ImmunityBio on March 24 for "Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies" (California Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,584,138, issued on March 24, was assigned to ImmunityBio Inc. (San Diego).

"Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies" was invented by Hans G. Klingemann (Culver City, Calif.), Laurent H. Boissel (Culver City, Calif.) and Nathan T. Schomer (Culver City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are modified NK-92(R) cells comprising one or more nucleic acids encoding i) a homing receptor, ii) Antigen Binding Protein (ABP) or Chimeric Antigen Recpetor (CAR) that specifically binds to a target antigen, iii) an Fc Receptor such a...